Ingrid Sassoon

USPTO Granted Patents = 7 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

Sanofi-a Ventis Deutschland Gmbh

patents

Years Active: 2008-2017

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9676864 - Antibodies that specifically bind to the EphA2 receptor (2017-06-13),

2. 8668910 - Antibodies that specifically bind to the EphA2 receptor (2014-03-11),

3. 7968546 - Pyridazinone kinase inhibitors (2011-06-28),

4. 7754713 - 4-benzimidazol-2-ylpyridazin-3-one derivatives (2010-07-13),

5. 7507734 - Pyridazinone derivatives (2009-03-24),

6. 7470689 - 4-benzimidazol-2-ylpyridazin-3-one derivatives (2008-12-30),

7. 7462613 - Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them (2008-12-09),

Title: The Innovative Mind of Ingrid Sassoon

Introduction: Ingrid Sassoon, a pioneering inventor hailing from Villejuif, France, is known for her groundbreaking contributions to the world of technology and innovation.

Latest Patents: Ingrid Sassoon's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power efficiency and storage solutions.

Career Highlights: With a career spanning over two decades, Ingrid Sassoon has established herself as a leading figure in the renewable energy sector, with numerous awards recognizing her innovative work.

Collaborations: Throughout her career, Ingrid Sassoon has collaborated with top research institutions and universities worldwide to further the development of sustainable energy solutions.

Conclusion: Ingrid Sassoon's passion for innovation and dedication to creating a more sustainable future continue to inspire generations of inventors and researchers in the field of renewable energy.

This text is generated by artificial intelligence and may not be accurate.